The human equivalent CD141+ CLEC-9A+ DCs have been found in TDLNs and were responsible for the cross presentation and activation of anti-tumour T cells in melanoma patients (Sluijter et al., 2015). This evidence concerns the gene CLEC9A and neoplasm.